As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
All content for Built Environment Matters is the property of Bryden Wood and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
Climate Resilience in UK Housing: Preventing Overheating in Net Zero Homes | The Bryden Wood Podcast
Built Environment Matters
49 minutes
4 months ago
Climate Resilience in UK Housing: Preventing Overheating in Net Zero Homes | The Bryden Wood Podcast
The UK's push toward net zero has dramatically improved building insulation and airtightness. But there's an unintended consequence that could prove dangerous: overheating. As climate change brings more extreme heat to Britain, these highly insulated homes risk becoming dangerously hot without adequate cooling strategies. In this episode, co-founder Martin Wood explores climate resilience in residential design with Helen Hough and Pablo Gugel from our sustainability team. With Pablo's Spanish...
Built Environment Matters
As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design. Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian arg...
